| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 3848826 | American Journal of Kidney Diseases | 2013 | 8 Pages |
Abstract
We were unable to show a benefit of the combination of lisinopril and irbesartan compared to either agent alone at optimal high doses on the risk of progression of type 2 diabetic nephropathy.
Keywords
Related Topics
Health Sciences
Medicine and Dentistry
Nephrology
Authors
Gema MD, José MD, Vicente MD, Soledad GarcÃa MD, Manuel MD, Marian MD, Victoria MD, Javier MD, Francisco MD, Ana MD, Eduardo MD, PRONEDI Study Group PRONEDI Study Group,